Transactiva has developed expression vectors suitable for constitutive, seed-specific or light-induced synthesis of therapeutic proteins in plants. These vectors are used together with tested transformation and regeneration protocols for the generation of appropriate production lines.

The proteins produced by Transactiva are pharmacologically active and characterized, bioequivalent with respect to the corresponding wild-type forms.

This site uses only technical cookies. Third-party cookies are installed by using it, read more. Accept the use of all cookies